Drugs / RG1671
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00517816 | Oct 2007 → Jul 2009 | asthma | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RG1671 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00517816 ↗ |
| Route | Intravenous | “Administered iv at escalating doses (with a starting dose of 0.0015mg)” NCT00517816 ↗ |